Home/Pelage Pharmaceuticals/Catherine J. Friedman

CJ

Catherine J. Friedman

Chair of the Board (GV)

Pelage Pharmaceuticals

Therapeutic Areas

Dermatology Hair Loss (Alopecia)

Pelage Pharmaceuticals Pipeline

Drug	Indication	Phase
PP405	Androgenetic Alopecia (Pattern Hair Loss)	Phase 2a

Leadership Team at Pelage Pharmaceuticals

Daniel Gil, PhD

Chief Executive Officer

William Lowry, PhD

President & Co-Founder

Christina Weng, MD

Chief Medical Officer

Nathan Wheeler, MPH

Chief Operating Officer

View full Pelage Pharmaceuticals profile